BioPharma Dive 23 mar 2026 Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results
BioPharma Dive 4 feb 2026 Earnings roundup: Amgen vs. FDA, Pfizer’s defense and Merck’s $70B-in-sales plan
BioPharma Dive 12 ene 2026 JPM26: US biotech’s ‘Sputnik moment,’ Pfizer’s obesity ambitions and Bristol Myers’ big year